Peak Bio, Inc.
PKBO · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $5,119 | $231 |
| - Cash | $0 | $0 | $862 | $236 |
| + Debt | $0 | $0 | $7,345 | $12,298 |
| Enterprise Value | $3 | $5 | $11,602 | $12,293 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | $3,064 | -$1,607 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | $1,714 | -$2,078 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.007 | -0.006 | 0.06 | -0.09 |
| % Growth | -11.3% | -110.3% | 167% | – |
| Operating Cash Flow | – | – | -$2,370 | -$905 |
| Capital Expenditures | – | – | $0 | $0 |
| Free Cash Flow | – | – | -$2,370 | -$905 |